Search research articles
Contact Us
Filters
Showing results (421-430 of 428) with videos related to
Page
of 43
Sort By:
You have reached the last page of results.
This site can display upto 428 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 1998
Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support
A D Elias, C Wheeler, L J Ayash, et al.
Journal of the National Cancer Institute
|
August 27, 1998
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B
D R Budman, D A Berry, C T Cirrincione, et al.
Annals of Internal Medicine
|
September 1, 1973
Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission
E Frei, J K Luce, J F Gamble, et al.
The American Journal of Medicine
|
March 1, 1980
High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity
E Frei, R H Blum, S W Pitman, et al.
Topics in Catalysis
|
April 2, 2019
The Role of Adsorbed and Subsurface Carbon Species for the Selective Alkyne Hydrogenation Over a Pd-Black Catalyst: An <i>Operando</i> Study of Bulk and Surface
J J Velasco-Vélez, D Teschner, F Girgsdies, et al.
Journal of Clinical Pathology
|
June 19, 2013
Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma
E Frei, C Visco, Z Y Xu-Monette, et al.
Science (New York, N.Y.)
|
June 23, 1972
Newsgathering
E Hirschberg, S C Joseph Fu, W R Frisell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 1, 1997
High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes
C Wheeler, C Eickhoff, A Elias, et al.
Page
of 43
Search research articles
Search
Showing results (421-430 of 428) with videos related to
Sort By:
Page
of 43
You have reached the last page of results.
This site can display upto 428 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 1998
Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support
A D Elias, C Wheeler, L J Ayash, et al.
Journal of the National Cancer Institute
|
August 27, 1998
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B
D R Budman, D A Berry, C T Cirrincione, et al.
Annals of Internal Medicine
|
September 1, 1973
Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission
E Frei, J K Luce, J F Gamble, et al.
The American Journal of Medicine
|
March 1, 1980
High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity
E Frei, R H Blum, S W Pitman, et al.
Topics in Catalysis
|
April 2, 2019
The Role of Adsorbed and Subsurface Carbon Species for the Selective Alkyne Hydrogenation Over a Pd-Black Catalyst: An <i>Operando</i> Study of Bulk and Surface
J J Velasco-Vélez, D Teschner, F Girgsdies, et al.
Journal of Clinical Pathology
|
June 19, 2013
Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma
E Frei, C Visco, Z Y Xu-Monette, et al.
Science (New York, N.Y.)
|
June 23, 1972
Newsgathering
E Hirschberg, S C Joseph Fu, W R Frisell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 1, 1997
High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes
C Wheeler, C Eickhoff, A Elias, et al.
Page
of 43